Candriam SCA’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-324,079
| Closed | -$30.1M | – | 865 |
|
|
2021
Q4 | $30.1M | Sell |
324,079
-302,239
| -48% | -$28.1M | 0.19% | 129 |
|
|
2021
Q3 | $37.3M | Hold |
626,318
| – | – | 0.25% | 95 |
|
|
2021
Q2 | $42.7M | Buy |
626,318
+194,269
| +45% | +$13.2M | 0.29% | 77 |
|
|
2021
Q1 | $31.9M | Hold |
432,049
| – | – | 0.27% | 96 |
|
|
2020
Q4 | $33.2M | Buy |
432,049
+62,493
| +17% | +$4.8M | 0.26% | 96 |
|
|
2020
Q3 | $27.6M | Sell |
369,556
-84,519
| -19% | -$6.32M | 0.26% | 95 |
|
|
2020
Q2 | $28.6M | Buy |
454,075
+57,275
| +14% | +$3.61M | 0.3% | 83 |
|
|
2020
Q1 | $17.6M | Hold |
396,800
| – | – | 0.2% | 119 |
|
|
2019
Q4 | $18M | Buy |
396,800
+31,000
| +8% | +$1.41M | 0.19% | 119 |
|
|
2019
Q3 | $16.7M | Buy |
365,800
+83,000
| +29% | +$3.8M | 0.22% | 106 |
|
|
2019
Q2 | $16.5M | Hold |
282,800
| – | – | 0.21% | 111 |
|
|
2019
Q1 | $12.7M | Buy |
282,800
+5,000
| +2% | +$224K | 0.16% | 149 |
|
|
2018
Q4 | $10.8M | Buy |
277,800
+85,830
| +45% | +$3.34M | 0.17% | 144 |
|
|
2018
Q3 | $8.83M | Buy |
191,970
+93,470
| +95% | +$4.3M | 0.12% | 210 |
|
|
2018
Q2 | $4.3M | Buy |
98,500
+49,500
| +101% | +$2.16M | 0.07% | 326 |
|
|
2018
Q1 | $1.94M | Buy |
+49,000
| New | +$1.94M | 0.03% | 486 |
|